$ISCO is at a major advantage thanks to having its
Post# of 18429
![Avatar](/images/ProfileImages/no_avatar_available.jpg)
Quote:
"Because of the complexity involved in manufacturing live human cell products, having our own GMP facility is not only a strategic advantage, but also allows us to control the production costs. We continue to anticipate, subject to regulatory agency approval, beginning the clinical trial in early 2015 and will provide a further update in the near future."
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)